These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21948162)

  • 1. Orthotopic model of human pancreatic ductal adenocarcinoma and cancer cachexia in nude mice.
    Jones-Bolin S; Ruggeri B
    Curr Protoc Pharmacol; 2007 Jun; Chapter 14():Unit 14.3. PubMed ID: 21948162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthotopic models of human gastric carcinoma in nude mice: applications for study of tumor growth and progression.
    Jones-Bolin S; Ruggeri B
    Curr Protoc Pharmacol; 2007 Jun; Chapter 14():Unit 14.4. PubMed ID: 21948163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical nude mouse metastatic model for highly malignant human pancreatic cancer.
    An Z; Wang X; Kubota T; Moossa AR; Hoffman RM
    Anticancer Res; 1996; 16(2):627-31. PubMed ID: 8687107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.
    Al Haddad AH; Adrian TE
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1499-515. PubMed ID: 25078674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.
    Shukla SK; Dasgupta A; Mehla K; Gunda V; Vernucci E; Souchek J; Goode G; King R; Mishra A; Rai I; Nagarajan S; Chaika NV; Yu F; Singh PK
    Oncotarget; 2015 Dec; 6(38):41146-61. PubMed ID: 26510913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.
    Sperveslage J; Frank S; Heneweer C; Egberts J; Schniewind B; Buchholz M; Bergmann F; Giese N; Munding J; Hahn SA; Kalthoff H; Klöppel G; Sipos B
    Int J Cancer; 2012 Aug; 131(4):E371-81. PubMed ID: 22020953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma.
    Miknyoczki SJ; Chang H; Klein-Szanto A; Dionne CA; Ruggeri BA
    Clin Cancer Res; 1999 Aug; 5(8):2205-12. PubMed ID: 10473107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma.
    Mitsunaga S; Kasamatsu E; Machii K
    Support Care Cancer; 2020 Nov; 28(11):5271-5279. PubMed ID: 32103356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State of the art and future directions of pancreatic ductal adenocarcinoma therapy.
    Neuzillet C; Tijeras-Raballand A; Bourget P; Cros J; Couvelard A; Sauvanet A; Vullierme MP; Tournigand C; Hammel P
    Pharmacol Ther; 2015 Nov; 155():80-104. PubMed ID: 26299994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An orthotopic model of ductal adenocarcinoma of the pancreas in severe combined immunodeficient mice representing all steps of the metastatic cascade.
    Alves F; Contag S; Missbach M; Kaspareit J; Nebendahl K; Borchers U; Heidrich B; Streich R; Hiddemann W
    Pancreas; 2001 Oct; 23(3):227-35. PubMed ID: 11590317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
    Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH
    Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens.
    Fu X; Guadagni F; Hoffman RM
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5645-9. PubMed ID: 1608975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.
    Gerber MH; Underwood PW; Judge SM; Delitto D; Delitto AE; Nosacka RL; DiVita BB; Thomas RM; Permuth JB; Hughes SJ; Wallet SM; Judge AR; Trevino JG
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy.
    Erstad DJ; Sojoodi M; Taylor MS; Ghoshal S; Razavi AA; Graham-O'Regan KA; Bardeesy N; Ferrone CR; Lanuti M; Caravan P; Tanabe KK; Fuchs BC
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29903803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
    Pergolini I; Morales-Oyarvide V; Mino-Kenudson M; Honselmann KC; Rosenbaum MW; Nahar S; Kem M; Ferrone CR; Lillemoe KD; Bardeesy N; Ryan DP; Thayer SP; Warshaw AL; Fernández-Del Castillo C; Liss AS
    PLoS One; 2017; 12(8):e0182855. PubMed ID: 28854237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia.
    Spadafora V; Pryce BR; Oles A; Talbert EE; Romeo M; Vaena S; Berto S; Ostrowski MC; Wang DJ; Guttridge DC
    BMC Cancer; 2024 Apr; 24(1):414. PubMed ID: 38570770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse Models of Pancreatic Ductal Adenocarcinoma.
    Ponz-Sarvise M; Tuveson DA; Yu KH
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):609-17. PubMed ID: 26226900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel "patient-like" treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice.
    Furukawa T; Kubota T; Watanabe M; Kitajima M; Hoffman RM
    Cancer Res; 1993 Jul; 53(13):3070-2. PubMed ID: 8319214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.